Literature DB >> 2887899

Alternative mechanism of action of "anti-oestrogens" in breast cancer.

S R Ebbs, J V Roberts, M Baum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887899     DOI： 10.1016/s0140-6736(87)93004-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Effects of the antiestrogen toremifene on growth of the human mammary carcinoma cell line MCF-7.

Authors:  R Grenman; K M Laine; P J Klemi; S Grenman; D J Hayashida; H Joensuu
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment.

Authors:  S Pyrhönen; R Valavaara; J Vuorinen; A Hajba
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

3.  Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancer.

Authors:  V J Wiebe; C C Benz; I Shemano; T B Cadman; M W DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.

Authors:  J Bishop; R Murray; L Webster; P Pitt; K Stokes; A Fennessy; I Olver; G Leber
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Topical toremifene: a new approach for cutaneous melanoma?

Authors:  J Maenpaa; T Dooley; G Wurz; J VandeBerg; E Robinson; V Emshoff; P Sipila; V Wiebe; C Day; M DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  High dose toremifene for estrogen and progesterone receptor negative metastatic breast cancer: a phase II trial of the Cancer and Leukemia Group B (CALGB).

Authors:  J J Perry; D A Berry; R B Weiss; D M Hayes; D B Duggan; I C Henderson
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

7.  Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trial.

Authors:  L E Stenbygaard; J Herrstedt; J F Thomsen; K R Svendsen; S A Engelholm; P Dombernowsky
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  In vitro sensitivity test of breast cancer cells to hormonal agents in a radionucleotide-incorporation assay.

Authors:  T Watanabe; J Z Wu; K Morikawa; M Fuchigami; M Kuranami; I Adachi; K Yamaguchi; K Abe
Journal:  Jpn J Cancer Res       Date:  1990-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.